SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is experiencing heightened volatility and community speculation, with investors tracking options flow and potential gamma exposure as the stock tests key technical levels. While discussions remain centered on the prospect of a short squeeze and long-term turnaround efforts, the community is actively debating whether upcoming corporate actions or market technicals will act as the catalyst for sustained upward momentum.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending as investors position for a potential short squeeze ahead of its upcoming earnings report, with the community highlighting high borrow rates and limited share availability. Bullish sentiment is being driven by speculation regarding potential partnerships and the strategic value of recent acquisitions, leading retail traders to advocate for holding positions to put pressure on short sellers.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is seeing intense trading activity as investors react to a private placement and a new licensing deal for its anti-IgE asset, leading to speculation about a potential short squeeze. The community remains divided, with some traders targeting significant upside from the company's clinical pipeline, while others warn of volatility and structural risks following a recent reverse stock split.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as a massive battleground between speculative retail bulls and bears, driven by intense short squeeze chatter and psychological milestones around the 100 level. Investors are closely monitoring the company's manufacturing progress and government ties, with the community actively debating whether the stock's parabolic ascent is fueled by legitimate long-term turnaround potential or a temporary bubble detached from current financial performance.

AIOS Tech, Inc. is an investment holding company, which engages in the provision of financing solutions to small- and mid-size enterprises. The company was founded on May 29, 2012 and is headquartered in Shanghai, China.

AIOS Tech Inc. - Ordinary Shares - Class A

AIOS Tech Inc.

AIOS is trending due to significant volatility and volume, with the community actively debating whether the stock is a prime candidate for a short squeeze or a potential pump-and-dump trap linked to share dilution concerns. Traders are closely watching micro-float dynamics and pivot points as the stock maintains heavy interest from day traders seeking momentum plays.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant volatility as investors digest a massive earnings beat and a newly announced six-billion-dollar share buyback, leading to a surge in bullish analyst price target revisions. While some are treating the stock's recent parabolic rally as a sell-the-news event, the community remains intensely divided between those betting on a sustained AI-driven memory supercycle and those calling for a sharp correction from current highs.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is experiencing intense volatility and bearish sentiment as investors weigh strong AI-driven infrastructure demand and capacity expansion against persistent concerns over management integrity, governance, and past legal issues. The community remains deeply divided, with bulls pointing to the company's critical role in the AI hardware supply chain as a structural discount, while bears emphasize a lack of trust in leadership and ongoing uncertainty ahead of the upcoming earnings report.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is seeing heightened volatility as investors grapple with conflicting signals from geopolitical tensions and ongoing sector rotation. While small caps exhibit price resilience, market participants are actively debating whether these levels represent sustainable momentum or a precarious build-up before a broader market pivot.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is experiencing intense volatility as investors debate the impact of potential tariff shifts, insider activity, and broader market sentiment regarding consumer discretionary spending. While some community members are treating the current price action as a generational buying opportunity due to strong brand growth and product demand, others remain cautious, highlighting technical bearish trends and ongoing uncertainty surrounding the stock's valuation.

Urban One, Inc. is a multi-media company, which engages in radio broadcasting that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment consists of all radio broadcast results of operations and low powered television operations. The Reach Media segment consists of the results of operations for the related activities and operations of the company’s syndicated shows. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One and CLEO TV operations. The company was founded by Catherine L. Hughes in 1980 and is headquartered in Silver Spring, MD.

Urban One Inc - Ordinary Shares - Class A

Urban One Inc

Urban One is gaining attention as traders speculate on potential price action and volatility ahead of the Juneteenth period, a timeframe that has historically triggered significant speculative momentum in the stock. Community discussion is currently centered on these seasonal trends, low float dynamics, and persistent interest in the stock's potential for sudden, volume-driven swings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

bioAffinity Technologies Launches New Study To Expand Use of CyPath Lung Technology for Asthma and COPD Diagnosis and Treatment

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced a pilot study with Brooke Army...

bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?

BIAF is sharpening its focus on CyPath Lung, streamlining unprofitable services and pushing validation studies as it expands its lung-disease pipeline.

New Case Study: bioAffinity Technologies CyPath Lung Diagnostic Supports Physicians Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a new clinical case study...

bioAffinity Technologies CyPath Lung to Be Featured at Cleveland Clinic Annual Advances in Early Lung Cancer Detection Symposium April 16

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, announces that its CyPath Lung test will be featured at...

<ul class="summary-bullets"><li>CyPath uses flow cytometry and AI to provide “likely” or “unlikely” malignancy results.</li><li>Rising pulmonary nodules and lung cancer survivors could drive market revenue to over $560 million.</li><li>bioAffinity’s commercial initiatives include expanding physician sites, peer education, and integration into clinical workflows.</li></ul>bioAffinity Technologies, Inc. (BIAF) announced on Wednesday that its CyPath Lung test has surpassed sales expectations in the first quarter of 2026, recording a 146% year-over-year increase in unit sales.CyPath Lung combines flow cytometry with AI to deliver clear “likely” or “unlikely” malignancy results to physicians. Real-world applications suggest the test can detect lung cancer at Stage 1A, improving treatment outcomes, and reduce unnecessary invasive procedures when malignancy risk is low.<h2 class="st-heading-2">Strong Market Demand</h2>Estimates from the U.S. Preventive Services Task Force suggest that indeterminate pulmonary nodules detected in the U.S. will increase 62%, from 2.9 million in 2025 to 4.7 million by 2030. The number of lung cancer survivors is also expected to rise from 680,000 to more than 871,000 over the same period.&nbsp;Capturing just 10% of these markets could generate $358 million in revenue for CyPath Lung, growing to over $560 million in five years, driven by a 10% compound annual growth rate fueled by broader screening adoption and AI-enhanced imaging technologies.<blockquote>“CyPath Lung is designed to address a critical gap in the diagnostic pathway by supporting lung cancer risk assessment, pulmonary nodule management and post-treatment surveillance.”-Maria Zannes, President and CEO of bioAffinity Technologies</blockquote>Following the update, bioAffinity stock traded over 8% higher in Wednesday’s premarket.&nbsp;On Stocktwits, retail sentiment around the stock remained in ‘bearish’ territory while message volume shifted to ‘low’ from ‘normal’ levels in 24 hours.&nbsp;<h2 class="st-heading-2">Commercial Strategy Boosts Adoption</h2>bioAffinity has focused on CyPath Lung as its flagship product, expanding ordering sites, promoting peer-to-peer education among pulmonologists, and integrating the test into routine lung cancer risk assessment workflows.&nbsp;Revenue for CyPath Lung rose 87% year-over-year in 2025, while test units sold grew 99% compared to 2024.BIAF stock has gained over 260% year-to-date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/msft-stock-struggles-weakest-magnificent-seven-in-q1-and-now-it-is-spending-5-5-b-more-on-ai/cZ7HZG9RInw">MSFT Stock Struggles As Weakest Of Magnificent Seven In Q1 – And Now It Is Spending $5.5B More On AI</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the BioAffinity Technologies logo is displayed on the screen of a tablet.

BIAF Stock Gains As CyPath Sales Surge 146% In Q1

bioAffinity Technologies, Inc. (BIAF) announced on Wednesday that its CyPath Lung test has surpassed sales expectations in the first quarter of 2026, recording a 146% year-over-year increase in unit sales.

Equity

The test is capable of identifying lung cancer at Stage 1A, enhancing chances for effective treatment.


bioAffinity Technologies CyPath Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that unit sales for its CyPath Lung...

<ul class="summary-bullets"><li>Urban-Gro’s merger with Flash Sports and Media marked a notable transition beyond indoor agriculture into sports-focused media.</li><li>Turbo Energy benefited from escalating tensions in the Middle East that sent energy prices higher.</li><li>bioAffinity reported strong sales growth for its lung diagnostic product, CyPath, and ambitious 100% growth guidance in 2026.</li></ul>A handful of lesser-known companies stole the spotlight in March, surging ahead of the broader market amid decisive operational shifts and real-world execution.Urban-gro, Inc. (UGRO), Turbo Energy S.A. (TURB), AleAnna, Inc. (ANNA), EpicQuest Education Group International (EEIQ), and bioAffinity Technologies, Inc. (BIAF) posted triple-digit percent gains during the month.<h2 class="st-heading-2">Shift Toward Execution Over Hype</h2>While large-cap technology names struggled amid sector rotation, these smaller firms capitalized on geopolitical disruptions, internal restructuring, and performance milestones to deliver outsized gains.Urban-Gro staged a sharp recovery after regaining compliance with Nasdaq listing standards in early March. The removal of delisting concerns lifted investor confidence. At the same time, its merger with Flash Sports and Media marked a notable transition beyond indoor agriculture into sports-focused media and marketing, reshaping its growth narrative.<a href="https://stocktwits.com/symbol/UGRO">Urban-Gro stock</a> traded over 4% higher in Tuesday’s premarket and has surged over 731% in March.&nbsp;<h2 class="st-heading-2">Shielding From Energy Shocks And The European LNG Supply Crisis</h2>Turbo Energy benefited from escalating tensions in the Middle East that sent energy prices higher. Its AI-powered energy storage systems gained traction among European industrial clients seeking to stabilize operating costs. On March 6, the company disclosed a $53 million backlog in industrial orders, further reinforcing optimism around its standing in the energy security space.&nbsp;<a href="https://stocktwits.com/symbol/TURB">Turbo Energy stock</a> traded over 6% lower in Tuesday’s premarket and has posted a gain of over 314% in March.&nbsp;&nbsp;AleAnna surged as supply shocks rattled global liquefied natural gas markets. Disruptions tied to the Middle East conflict tightened availability, elevating the strategic importance of the company’s Italian gas assets.&nbsp;On March 12, the company announced significant increases to its proved reserves across key Po Valley fields, following the completion of its final 2025 reserves report.&nbsp;<a href="https://stocktwits.com/symbol/ANNA">AleAnna stock</a> traded over 2% higher in Tuesday’s premarket, with over 25% gains in March.&nbsp;<h2 class="st-heading-2">Low Float And Growth Milestones&nbsp;</h2>After completing a 1-for-16 reverse stock split in late February, EpicQuest Education Group began March with a reduced float of about 1.48 million shares, allowing for extreme price velocity on relatively low buying volume.<a href="https://stocktwits.com/symbol/EEIQ">EpicQuest stock</a> has surged by over 242% in March.&nbsp;Meanwhile bioAffinity Technologies delivered one of the most dramatic moves, nearly doubling in a single trading session on March 13. Strong sales growth for its lung diagnostic product, CyPath, and ambitious 100% growth guidance in 2026, suggested the company had successfully transitioned from the development stage to revenue-generating operations.<a href="https://stocktwits.com/symbol/BIAF">BIAF stock</a> has increased by over 233% in March.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-red-cat-holding-stock-up-premarket/cZEPrK6RIVP">Why Is RCAT Stock Rising Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

UGRO, TURB, ANNA, EEIQ, BIAF: These Five Stocks Outpaced Big Tech With Massive March Returns

As big tech faltered during sector shifts, share prices of some of the smaller companies surged amid restructuring efforts and key business achievements.

What's Going On With bioAffinity Technologies Stock Wednesday?

bioAffinity Technologies Inc (NASDAQ: BIAF) shares trade higher in Wednesday's premarket after announcing a live virtual roundtable for its CyPath Lung test.read more...

bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath Lung into Pulmonary Practice

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced it will host the first of a series of live...

BIAF Stock Surges 85%, Breaks 200-DMA For The First Time In Nearly A Year – Here’s What’s Driving The Rally

The stock has been on a sharp uptrend, gaining more than 160% over the past week on the back of bullish CyPath Lung estimates.

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

BIAF
BioAffinity Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BIAF News

BIAFBioAffinity Technologies Inc